Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nada Albarakati"'
Publikováno v:
Frontiers in Neuroscience, Vol 18 (2024)
Long non-coding RNAs (lncRNAs) have emerged as critical players in brain development and disease. These non-coding transcripts, which once considered as “transcriptional junk,” are now known for their regulatory roles in gene expression. In brain
Externí odkaz:
https://doaj.org/article/ec7a52afb3cb413ea1e5c3cad3842058
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract Human epidermal growth factor receptor 2 (HER2/ERBB2) factor is known to be implicated in many malignancies and the potential of it as a prognostic biomarker was reported years ago. Molecular subtypes of HER2/ERBB2 negative and positive with
Externí odkaz:
https://doaj.org/article/363a5d57e4dd43cd878517dd150be30b
Autor:
Mikhlid H Almutairi, Turki M Alrubie, Alaa T Alshareeda, Nada Albarakati, Alhomidi Almotiri, Abdullah M Alamri, Bader O Almutairi, Mohammad Alanazi
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0307724 (2024)
Colon cancer (CC) is a significant cause of death worldwide, particularly in Saudi Arabia. To increase the accuracy of diagnosis and treatment, it is important to discover new specific biomarkers for CC. The main objectives of this research are to id
Externí odkaz:
https://doaj.org/article/648dd2b1cd674f71939be0879030cd04
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background The glutathione S-transferases (GSTs) are a superfamily of phase II detoxifying enzymes that inactivates a wide variety of potential carcinogens through glutathione conjugation. Polymorphic changes in the GST genes have been repor
Externí odkaz:
https://doaj.org/article/1a626f1a8a3846ca9ed0a5173788daf9
Autor:
Taoufik Nedjadi, Nada Albarakati, Hicham Benabdelkamel, Afshan Masood, Assim A. Alfadda, Jaudah Al-Maghrabi
Publikováno v:
Life, Vol 11, Iss 12, p 1294 (2021)
Background: Bladder cancer is a life-threatening disease and a major cause of cancer-associated complications. The main challenges confronted during the clinical management of bladder cancer are associated with recurrence and disease progression to t
Externí odkaz:
https://doaj.org/article/88a56f687cbf453c8a30d5c27ea9df37
Autor:
Srinivasan Madhusudan, Ian O. Ellis, Emad A. Rakha, Stephen Chan, Graham Ball, Claire Seedhouse, Nada Albarakati, Claire Hawkes, Rachel Abbotts, Tarek Abdel-Fatah, Rebeka Sultana
PDF file - 322K, Supplemental Figure 1. Disease free survival (DFS) and distant metastasis free survival (DMFS) in breast cancer whole cohort (A), Lymph node negative (B) and lymphnode positive (C). Supplemental Figure 2. Disease free survival (DFS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41fffd69f6d1fd9f31806f6ebc8b79ed
https://doi.org/10.1158/0008-5472.22400370.v1
https://doi.org/10.1158/0008-5472.22400370.v1
Supplementary Tables 1 - 4 from Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy
Autor:
Srinivasan Madhusudan, Ian O. Ellis, Emad A. Rakha, Stephen Chan, Graham Ball, Claire Seedhouse, Nada Albarakati, Claire Hawkes, Rachel Abbotts, Tarek Abdel-Fatah, Rebeka Sultana
PDF file - 104K, Supplemental Table S1: Clinicopathological characteristics of whole breast cancer cohort Supplemental Table S2: Clinicopathological characteristics of validation setSupplementary Table S3: Antigens, primary antibodies, clone, source,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a34a3e894a3aec930036ca634262cad
https://doi.org/10.1158/0008-5472.22400367.v1
https://doi.org/10.1158/0008-5472.22400367.v1
Autor:
Srinivasan Madhusudan, Ian O. Ellis, Emad A. Rakha, Stephen Chan, Graham Ball, Claire Seedhouse, Nada Albarakati, Claire Hawkes, Rachel Abbotts, Tarek Abdel-Fatah, Rebeka Sultana
XRCC1 is a key component of DNA base excision repair, single strand break repair, and backup nonhomologous end-joining pathway. XRCC1 (X-ray repair cross-complementing gene 1) deficiency promotes genomic instability, increases cancer risk, and may ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b22245bc2a92ca79a34d8f7ef73c8ae
https://doi.org/10.1158/0008-5472.c.6505569
https://doi.org/10.1158/0008-5472.c.6505569
Autor:
Jaudah Al-Maghrabi, Assim A. Alfadda, Hicham Benabdelkamal, Afshan Masood, Nada Albarakati, Ahmed Al-Sayyad, Taoufik Nedjadi, Ibrahim O. Alanazi, Adel Al-Ammari
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
The identification of clinically-relevant early diagnostic and prognostic protein biomarkers is essential to maximize therapeutic efficacy and prevent cancer progression. The aim of the current study is to determine whether aberrant plasma protein pr
Autor:
Hicham Benabdelkamel, Nada Albarakati, Jaudah Al-Maghrabi, Afshan Masood, Assim A. Alfadda, Taoufik Nedjadi
Publikováno v:
Life
Life; Volume 11; Issue 12; Pages: 1294
Life, Vol 11, Iss 1294, p 1294 (2021)
Life; Volume 11; Issue 12; Pages: 1294
Life, Vol 11, Iss 1294, p 1294 (2021)
Background: Bladder cancer is a life-threatening disease and a major cause of cancer-associated complications. The main challenges confronted during the clinical management of bladder cancer are associated with recurrence and disease progression to t